How does iron status influence thyroid hormone synthesis and levothyroxine therapy?

Iron's Critical Role in Thyroid Hormone Synthesis and Levothyroxine Efficacy

Iron deficiency significantly impairs thyroid hormone metabolism at multiple levels: it reduces thyroid peroxidase (TPO) activity needed for T4 synthesis, impairs hepatic conversion of T4 to active T3, and diminishes the therapeutic response to levothyroxine replacement therapy. 1

Mechanisms of Iron-Thyroid Interaction

Iron deficiency disrupts thyroid metabolism through three distinct pathways:

1. Impaired Thyroid Hormone Synthesis

• Iron is essential for TPO, the heme-containing enzyme that catalyzes the initial steps in thyroid hormone production 2
• Iron deficiency reduces TPO activity by up to 56% in severe deficiency states 2
• This occurs independently of food restriction effects 2

2. Reduced Peripheral Conversion

• Hepatic conversion of T4 to the active metabolite T3 depends on Type 1 5'-deiodinase, a selenoenzyme that requires adequate iron 1
• Iron deficiency shifts metabolism away from efficient oxidative pathways 3

3. Interference with Levothyroxine Absorption

• Ferrous sulfate directly binds to levothyroxine in the gastrointestinal tract, reducing absorption and potentially causing treatment failure 4
• The FDA label explicitly lists iron supplements (ferrous sulfate) as phosphate binders that may decrease T4 absorption 4
• Levothyroxine must be administered at least 4 hours apart from iron supplementation 4

Clinical Implications for Hypothyroid Patients

When Iron Deficiency and Hypothyroidism Coexist

The evidence strongly supports treating both conditions simultaneously rather than sequentially:

• Combined levothyroxine plus iron therapy produces superior hemoglobin increases (1.9 g/dL) compared to iron alone (0.4 g/dL) in patients with subclinical hypothyroidism and iron deficiency anemia 5, 6
• Iron therapy alone fails to adequately correct anemia when subclinical hypothyroidism is present 6
• The therapeutic response to oral iron is significantly enhanced when thyroid function is optimized 6

Critical caveat: When initiating combined therapy, the timing of administration is paramount. Failure to separate iron and levothyroxine by at least 4 hours will negate the benefits of both treatments 4.

Monitoring Requirements

For patients on concurrent iron and levothyroxine therapy:

• Check TSH 6-8 weeks after any change in iron supplementation, as iron status alterations may necessitate levothyroxine dose adjustments 7, 8
• A patient who becomes iron-replete may require less levothyroxine; conversely, developing iron deficiency increases levothyroxine requirements 8
• Monitor hemoglobin, ferritin, and transferrin saturation alongside thyroid function tests 9

Iron Status Assessment in Thyroid Disease

Serum ferritin <30 μg/L or hemoglobin <11 g/dL in pregnant women indicates iron deficiency that may impair thyroid function 10:

• Hemoglobin correlates more strongly with thyroid function than ferritin during pregnancy 10
• Iron-deficient pregnant women show higher TSH (2.31 vs 1.75 mIU/L) and lower free T4 (10.7 vs 13.3 pmol/L) 10
• Meta-regression demonstrates inverse correlation between hemoglobin and TSH, and direct correlation with free T4 10

Special Populations

Energy-Deficient Athletes

Iron deficiency compounds the hypometabolic state of low energy availability by:

• Impairing T4 synthesis and T4-to-T3 conversion 3
• Suppressing osteotrophic hormones (GH, IGF-1) through thyroid axis disruption 3
• Creating a vicious cycle where iron deficiency promotes energy deficiency through metabolic inefficiency 3

Pregnancy

• Pregnant women with subclinical hypothyroidism should receive levothyroxine to restore TSH to reference range, with particular attention to iron status 11
• Levothyroxine requirements frequently increase during pregnancy, necessitating TSH monitoring every 6-8 weeks 11
• Iron supplementation timing becomes even more critical given increased requirements for both nutrients 10

Practical Management Algorithm

For patients with confirmed hypothyroidism and iron deficiency:

1. Initiate levothyroxine at standard replacement dose (1.1-1.3 μg/kg/day) 7
2. Prescribe iron supplementation (typically 240 mg/day oral iron) 5, 6
3. Instruct strict 4-hour separation: levothyroxine upon waking, iron mid-afternoon or evening 4
4. Avoid concurrent administration with proton pump inhibitors, calcium, or other binding agents 4
5. Recheck TSH, free T4, hemoglobin, and ferritin at 6-8 weeks 7
6. Adjust levothyroxine dose based on TSH response, recognizing that improving iron status may reduce requirements 8

Common pitfall: Patients taking levothyroxine who develop unexplained TSH elevation should be questioned about new iron supplementation or multivitamin use containing iron 8. The solution is timing adjustment, not necessarily dose escalation.

The relationship between iron and thyroid metabolism is bidirectional and clinically significant—iron deficiency impairs thyroid hormone production and action, while optimizing thyroid function enhances the response to iron therapy 5, 6, 12.